share_log

康方生物：股東週年大會通告

AKESO: NOTICE OF ANNUAL GENERAL MEETING

HKEX ·  Jun 6 04:42
Summary by Moomoo AI
康方生物科技（開曼）有限公司（「康方生物」）將於2024年6月30日舉行股東週年大會，地點為中國廣東省中山市。會議將審議多項普通決議案，包括審核及採納截至2023年12月31日止年度的經審核綜合財務報表及董事會與核數師報告。此外，將進行董事重選，包括夏瑜博士、李百勇博士及王忠民博士的執行董事職位。會上還將續聘安永會計師事務所為核數師並授權董事會釐定酬金。大會將考慮授權董事在特定期間內配發新股份或購回公司股份，並將審議修訂2021年受限制股份單位計劃及購股權計劃。股東將有權委任代表出席大會並投票，而股份過戶登記將於2024年6月25日至30日暫停。董事會成員包括夏瑜博士（主席兼執行董事）、李百勇博士、王忠民博士、夏羽先生、周伊博士、謝榕剛先生、曾駿文博士、徐岩博士及TAN Bo先生。
康方生物科技（開曼）有限公司（「康方生物」）將於2024年6月30日舉行股東週年大會，地點為中國廣東省中山市。會議將審議多項普通決議案，包括審核及採納截至2023年12月31日止年度的經審核綜合財務報表及董事會與核數師報告。此外，將進行董事重選，包括夏瑜博士、李百勇博士及王忠民博士的執行董事職位。會上還將續聘安永會計師事務所為核數師並授權董事會釐定酬金。大會將考慮授權董事在特定期間內配發新股份或購回公司股份，並將審議修訂2021年受限制股份單位計劃及購股權計劃。股東將有權委任代表出席大會並投票，而股份過戶登記將於2024年6月25日至30日暫停。董事會成員包括夏瑜博士（主席兼執行董事）、李百勇博士、王忠民博士、夏羽先生、周伊博士、謝榕剛先生、曾駿文博士、徐岩博士及TAN Bo先生。
Akeso (Cayman) Limited ("Akeso") will hold its shareholder's annual meeting on June 30, 2024, in Zhongshan City, Guangdong Province, China. The meeting will consider multiple ordinary resolutions, including the review and adoption of the audited comprehensive financial statements and the board of directors' and auditor's reports for the year ended December 31, 2023. In addition, there will be director re-elections, including the Executive Director positions of Dr. Xia Yu, Dr. Li Baiyong, and Dr. Wang Zhongmin. The meeting will also reappoint Ernst & Young as the auditor and authorize the Board of Directors to determine their remuneration. The meeting will consider authorizing the Board of Directors to issue new shares or repurchase company shares within a specific period and will review the...Show More
Akeso (Cayman) Limited ("Akeso") will hold its shareholder's annual meeting on June 30, 2024, in Zhongshan City, Guangdong Province, China. The meeting will consider multiple ordinary resolutions, including the review and adoption of the audited comprehensive financial statements and the board of directors' and auditor's reports for the year ended December 31, 2023. In addition, there will be director re-elections, including the Executive Director positions of Dr. Xia Yu, Dr. Li Baiyong, and Dr. Wang Zhongmin. The meeting will also reappoint Ernst & Young as the auditor and authorize the Board of Directors to determine their remuneration. The meeting will consider authorizing the Board of Directors to issue new shares or repurchase company shares within a specific period and will review the amendment of the 2021 Restricted Stock Unit Plan and Stock Purchase Rights Plan. Shareholders have the right to appoint proxies to attend the meeting and vote, while share transfer registration will be suspended from June 25 to 30, 2024. Board of Directors members include Dr. Xia Yu (Chairman and Executive Director), Dr. Li Baiyong, Dr. Wang Zhongmin, Mr. Xia Yu, Dr. Zhou Yi, Mr. Xie Ronggang, Dr. Zeng Junwen, Dr. Xu Yan, and Mr. Tan Bo.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more